The identification of genomically associated radiosensitization in CREBBP/EP300 mutants is particularly of interest in HNSCC, and indeed in SCCs in general, as we have shown in the current study that mutations in these genes are associated with clinical radioresistance. This evidence concerns the gene EP300 and head and neck squamous cell carcinoma.